Format

Send to

Choose Destination
Adv Exp Med Biol. 2018;1062:265-276. doi: 10.1007/978-981-10-8727-1_19.

Structural Insights into the Broad-Spectrum Antiviral Target Endoplasmic Reticulum Alpha-Glucosidase II.

Author information

1
Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, UK.
2
Ecole Nationale Supérieure de Chimie de Montpellier, Montpellier Cedex 5, France.
3
Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, UK. nicole.zitzmann@bioch.ox.ac.uk.

Abstract

Targeting the host-cell endoplasmic reticulum quality control (ERQC) pathway is an effective broad-spectrum antiviral strategy. The two ER resident α-glucosidases whose sequential action permits entry in this pathway are the targets of glucomimetic inhibitors. Knowledge of the molecular details of the ER α-glucosidase II (α-Glu II) structure was limited. We determined crystal structures of a trypsinolytic fragment of murine α-Glu II, alone and in complex with key catalytic cycle ligands, and four different broad-spectrum antiviral iminosugar inhibitors, two of which are currently in clinical trials against dengue fever. The structures highlight novel portions of the enzyme outside its catalytic pocket which contribute to its activity and substrate specificity. These crystal structures and hydrogen-deuterium exchange mass spectrometry of the murine ER alpha glucosidase II heterodimer uncover the quaternary arrangement of the enzyme's α- and β-subunits, and suggest a conformational rearrangement of ER α-Glu II upon association of the enzyme with client glycoproteins.

KEYWORDS:

Antiviral iminosugar; Broad spectrum antiviral; Endplasmic reticulum quality control; Glucomimetic inhibitors; Hydrogen-deuterium exchange mass spectrometry

PMID:
29845539
DOI:
10.1007/978-981-10-8727-1_19
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center